(Q37568632)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

0 references

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Fabian Docagne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Fernando G Correa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

José Borrell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Carmen Guaza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

published in

Vitamins and Hormones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

207-230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Therapeutic potential of CB2 targeting in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Role of CB2 receptors in neuroprotective effects of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The endocannabinoid system is modulated in response to spinal cord injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid-based drugs as anti-inflammatory therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Therapeutic potential of cannabinoid-based drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid receptors and T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

A biosynthetic pathway for anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Presence and regulation of the endocannabinoid system in human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Anandamide suppresses nitric oxide and TNF-alpha responses to Theiler's virus or endotoxin in astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Novel selective and metabolically stable inhibitors of anandamide cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Like cops on the beat: the active role of resting microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Cannabinoid signaling in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Endocannabinoid signaling in microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Interleukin-12 and the regulation of innate resistance and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Astrocytes in culture produce anandamide and other acylethanolamides.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Genetic deletion of Fatty Acid Amide Hydrolase results in improved long-term outcome in chronic autoimmune encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

P2X7 receptors control 2-arachidonoylglycerol production by microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2809%2981009-1

7 January 2021

10.1016/S0083-6729(09)81009-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19647114%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference